Citius Oncology CTOR
NASDAQ CTOR
$0.98 -0.03 (-2.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Long-Term Investments (2022 - 2024)

Updated

Citius Oncology (CTOR) recorded Long-Term Investments of $49.15 million in fiscal Q2 2024 (quarter ended Jun 30, 2024), down 29.2% from $69.39 million a year earlier but up 1.2% from the prior quarter.

Analysis

Citius Oncology (CTOR) Long-Term Investments (2022 - 2024) Analysis & Trends

At the end of FY2023 (ended Dec 31, 2023), Citius Oncology reported Long-Term Investments of $72.57 million, up 7.0% from FY2022.

  • Across earlier fiscal years, Long-Term Investments came in at $67.81 million in FY2022.
  • Quarterly Long-Term Investments has ranged from $48.58 million in fiscal Q1 2024 to $72.57 million in fiscal Q4 2023 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Citius Oncology 106.82 Mn 106.82 Mn 1.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 49.15 Mn
Mar 31, 2024 48.58 Mn
Dec 31, 2023 72.57 Mn
Sep 30, 2023 70.63 Mn
Jun 30, 2023 69.39 Mn
Mar 31, 2023 68.57 Mn
Dec 31, 2022 67.81 Mn
API Access

Citius Oncology Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=CTOR&period=max&api_key=YOUR_API_KEY